What Are MOTS-c & SS-31?
A Mitochondrial Peptide Guide

MOTS-c and SS-31 are two of the most talked-about peptides in longevity, because they work where ageing begins: inside your mitochondria. Mitochondria are the tiny power plants in your cells, and their decline is central to how we age. This guide explains what each peptide is, how they differ, the honest state of the evidence, who they suit, and how to start on a doctor-led programme in South Africa.

Everything here was reviewed by Dr Chris van Zyl (registered as M.C. van Zyl, HPCSA MP0287067), who is licensed to both prescribe and dispense medicines under a Section 22C dispensing licence. Mitochondrial peptides are dispensed on a valid script after a medical questionnaire, with a consultation arranged when your screening calls for one.

Why do mitochondria matter for ageing?

Mitochondria produce almost all the energy your cells use, and they also help regulate metabolism and cell health. As we age, mitochondria become fewer and less efficient, which contributes to lower energy, slower recovery and age-related decline. This is why supporting mitochondrial function has become such a focus in longevity medicine, and why peptides that act on the mitochondria have attracted so much interest.

What is MOTS-c?

MOTS-c is a mitochondrial-derived peptide, meaning it is actually encoded inside the mitochondria rather than the cell nucleus. It is often described as an “exercise mimetic” because published research links it to activating AMPK, a master metabolic switch also triggered by exercise and fasting. It is studied for supporting insulin sensitivity, glucose handling and fat metabolism. Most of this evidence is still preclinical, so it is used as support under medical guidance rather than as a proven treatment.

What is SS-31 (elamipretide)?

SS-31, also known as elamipretide, is a peptide that targets the inner membrane of the mitochondria. It binds a lipid called cardiolipin and helps the membrane keep its structure, which improves how efficiently the mitochondria make energy and reduces oxidative stress. Unlike most peptides, SS-31 has been through clinical research, including studies on age-related decline in skeletal muscle and stamina, which gives it a stronger evidence base than many longevity compounds.

What is the difference between MOTS-c and SS-31?

They both target the mitochondria but in different ways. MOTS-c acts like a signal that nudges your metabolism toward the beneficial effects of exercise. SS-31 acts structurally, helping the mitochondria physically work better and resist damage. Because they work through different mechanisms, some longevity protocols use them together under doctor guidance rather than choosing one.

What are the benefits of mitochondrial peptides?

The benefits people look for are steadier energy, better metabolic health, improved recovery and resilience against the slow decline that comes with age. SS-31 in particular is studied for supporting muscle and stamina. It is honest to say individual responses vary and the field is still developing, so these are best understood as support for healthy ageing within a broader programme, not a guaranteed anti-ageing result.

What is the honest state of the evidence?

This matters, because these peptides are often oversold online. MOTS-c is largely backed by laboratory and animal research so far, with human data still emerging. SS-31 (elamipretide) is further along, having been tested in human clinical trials for mitochondrial conditions. So the two are not equal in how proven they are. A responsible approach treats them as promising, doctor-supervised support rather than established medicine, and sets realistic expectations.

Who are mitochondrial peptides suitable for?

They suit people focused on longevity, energy and metabolic health who already have their foundations in place, meaning good sleep, nutrition and regular training, and who want a more advanced protocol under medical supervision. They are generally not a first step for someone new to peptides. Your doctor confirms suitability during screening and checks for anything that needs extra care.

How are they taken, and are they safe?

Both are given as small subcutaneous injections using a prefilled pen, on a schedule set by your doctor. In the available research both are generally well tolerated, with side effects usually limited to mild injection-site reactions. The honest caveat, as with all newer peptides, is that long-term human safety data is limited, which is exactly why they are dispensed on a script after a doctor reviews your history.

Can they be combined with other peptides?

Yes, and in longevity programmes they often are, commonly alongside NAD+, which also supports cellular energy, under doctor guidance so the combination makes sense for your goals. Our team maps out a sensible protocol rather than stacking products for its own sake. You can see the full range on our peptides in South Africa hub.

How do I get MOTS-c or SS-31 in South Africa?

They are prescription items, so it starts with a short medical questionnaire that our registered doctor reviews, with a consultation arranged when your screening calls for one. Once a script is issued, your prefilled pen is couriered anywhere in South Africa with clear dosing instructions. Pricing and the full options are on our MOTS-c and SS-31 page.